Search results for

Biologic drugs, often made with the help of living organisms, are especially lucrative because they have scant competition from biosimilars, drugs akin to generics. It's a different story in Europe.

Trump administration efforts to undo Obama-era health insurance rules have helped increase sales of limited health plans that cost consumers less than traditional coverage.

Some state exchanges have begun allowing new enrollment to help ease consumers' worry about health care costs. It's also so the uninsured won't inadvertently spread the coronavirus by avoiding care.

Should "potential exposure" by a health worker to someone with coronavirus be enough to send that worker home for two weeks of self-quarantine? Health systems have begun debating relative risks.

Doctors say the machine that helps some people with sleep apnea keep their airway open at night won't be enough to help an ill COVID-19 patient breathe and could spread the coronavirus to bystanders.

About half of U.S. rural hospitals operate in the red on a good day. Now facing a pandemic, hospital CEOs warn that, without federal help, their doors may close when the community most needs them.

Even many symptomatic patients and exposed health workers who are able to get a COVID-19 test must wait nearly a week to get results. Others get results in hours. Here's why it varies so much.

A 39-year-old man fainted after getting a flu shot at work, so his colleagues called 911. The man turned out to be fine, but the trip to the emergency room cost him his annual deductible.

President Trump said that taming unexpected medical bills would be a top priority for his administration. The sentiment found support from many in Congress.

In a White House meeting with patients and doctors, President Trump directed his health secretary, Alex Azar, and labor secretary, Alex Acosta, to work on a solution for unexpected bills.

While some officials urge expansion of the Medicare system, several states are mulling a different way to ensure residents have affordable coverage: help them buy into a Medicaid-like plan.

As hospital chains and insurers across the U.S squeeze one another, hoping to increase their market share, many patients are suddenly finding their preferred doctors and hospitals are out of network.

Well-known insurers are selling new sorts of health plans outside the Affordable Care Act exchanges that may sound cheaper but aren't necessarily. Some, for example, charge extra for common surgeries.

Some states have begun using Medicare reimbursement rates to recalibrate how they pay hospitals. If the gamble pays off, more private-sector employers could start doing the same thing.

Surprise billing is one of the rare public policy issues that are both bipartisan and in need of a federal solution. A hearing on Capitol Hill looked to insurers and providers to help figure it out.

The Trump administration's plan to force some Medicaid recipients to work to maintain benefits took another hit Wednesday when a U.S. district judge blocked such work rules in Kentucky and Arkansas.

Inspectors are citing facilities more often than during the Obama administration. But in response to industry prodding, the average fine is nearly a third lower, and the total assessed is down.

A public hospital in Los Angeles gets over 1,000 unidentified patients a year. Most are quickly ID'd, but some require considerable gumshoe work — a task often complicated by medical privacy laws.

In 1991, the Supreme Court upheld restrictions on family planning providers that are similar to rules proposed by the Trump Administration. But Trump critics say the legal landscape has changed.

As recent arrivals to the U.S. are released from detention with health problems ranging from diarrhea to gaping wounds, doctors who are trying to help, with little federal support, feel the strain.

Unlike many private health plans, Medicare has no cap on out-of-pocket expenses for prescription drugs in Part D. As the cost of specialty drugs rises, some Medicare patients owe thousands of dollars.

A Senate hearing on Tuesday featuring pharmaceutical executives will tackle many issues raised in the historic Kefauver hearings, which led to tougher drug regulation. High prices remain a concern.

Should doctors warn patients of a policy threat that may not come to pass? That's the question pending, as the Trump administration weighs whether to deny green cards to immigrants on Medicaid.

Now that Colorado has expanded Medicaid coverage to include more low-income residents, hospitals are better off financially. But that hasn't stopped them from shifting costs to other insured patients.

Critics question claims by federal officials that CanaRX jeopardizes patient safety. Many U.S. companies, cities, counties and school districts rely on the firm to help employees get cheaper medicine.